CATX Perspective Therapeutics, Inc.: institutional ownership and insider trading
130 funds reported holding $309M of Perspective Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $28.0M, with 22 new positions and 30 funds selling out; over the last 12 months insiders bought $42.3K and sold $1.62M on the open market.
CATX revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$26.8M, EPS -0.22
- Quarter ended Mar 31, 2026: revenue n/a, net income −$26.2M, EPS -0.25
- Quarter ended Dec 31, 2025: revenue n/a, net income −$37.5M, EPS -0.51
- Quarter ended Sep 30, 2025: revenue n/a, net income −$26.0M, EPS -0.35
Famous investors holding CATX
- Izzy Englander (Millennium Management): $16.7M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $13.0M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $5.31M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $202K, 0.0% of the portfolio
Largest institutional holders of CATX
- BlackRock, Inc. (BLK) — $32.4M
- TCG Crossover Management, LLC — $27.0M
- Commodore Capital LP — $21.6M
- Avidity Partners Management LP — $21.5M
- STATE STREET CORP (STT, STT-PG) — $20.6M
- MILLENNIUM MANAGEMENT LLC — $16.7M
- VANGUARD CAPITAL MANAGEMENT LLC — $15.1M
- Affinity Asset Advisors, LLC — $14.4M
- CITADEL ADVISORS LLC — $13.0M
- Spruce Street Capital LP — $12.6M
Recent CATX insider trades
- Sep 4, 2026: Lantheus Holdings, Inc. sold 247,932 shares ($778K)
- Sep 2, 2026: Lantheus Holdings, Inc. sold 42,129 shares ($131K)
- Sep 1, 2026: Lantheus Alpha Therapy, LLC sold 113,914 shares ($357K)
- Sep 1, 2026: Lantheus Holdings, Inc. sold 35,769 shares ($112K)
5%+ owners
- Lantheus Holdings, Inc.: 7.7% (Schedule 13D/A, filed Sep 23, 2026)
- BlackRock, Inc.: 6.8% (Schedule 13G, filed Jul 29, 2026)
- Millennium Management LLC: 5.5% (Schedule 13G/A, filed Aug 13, 2026)
- STATE STREET CORPORATION: 5.3% (Schedule 13G, filed Aug 7, 2026)